BTX BlackRock Technology and Private Equity Term Trust

$7.22

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/19/2025

About BlackRock Technology and Private Equity Term Trust

Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.

Website: https://www.brooklynitx.com

Sector
TECHNOLOGY
Industry
GENERAL
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
748592
Address
NONE
Valuation
Market Cap
$1.26B
P/E Ratio
34.65
PEG Ratio
0.00
Price to Book
0.70
Performance
EPS
$-2.83
Dividend Yield
—
Profit Margin
0.00%
ROE
-427.20%
Technicals
50D MA
$6.82
200D MA
$7.38
52W High
$8.00
52W Low
$5.15
Fundamentals
Shares Outstanding
59M
Target Price
$3.00
Beta
nan

BTX EPS Estimates vs Actual

● Estimated
● Actual

BTX News & Sentiment

Oct 22, 2022 • Stocknews.com NEUTRAL
Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a report released on Saturday. The brokerage set a "hold" rating on the stock. Shares of Brooklyn ImmunoTherapeutics stock opened at $3.65 on Friday.
Oct 06, 2022 • Stocknews.com NEUTRAL
Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a note issued to investors on Thursday. The firm set a "hold" rating on the stock. BTX opened at $0.25 on Thursday.
Sep 28, 2022 • Stocknews.com NEUTRAL
Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Research Coverage Started at StockNews.com
Analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a report issued on Wednesday. The brokerage set a "hold" rating on the stock. NYSE:BTX opened at $0.23 on Wednesday.
Sep 21, 2022 • Stocknews.com NEUTRAL
Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Now Covered by StockNews.com
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a report published on Tuesday morning. The brokerage issued a hold rating on the stock. Shares of Brooklyn ImmunoTherapeutics stock opened at $0.29 on Tuesday.
Sep 15, 2022 • Stocknews.com SOMEWHAT-BULLISH
StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics ( NYSE:BTX )
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a report issued on Monday. The firm issued a hold rating on the stock. Shares of BTX stock opened at $0.36 on Monday.
Sep 08, 2022 • Stocknews.com NEUTRAL
Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics ( NYSE:BTX - Get Rating ) in a research note released on Wednesday. The firm issued a hold rating on the stock. Shares of BTX stock opened at $0.34 on Wednesday.
Sentiment Snapshot

Average Sentiment Score:

0.156
20 articles with scored sentiment

Overall Sentiment:

Bullish

BTX Reported Earnings

Apr 14, 2023
Mar 31, 2023 (Pre market)
0.14 Surprise
  • Reported EPS: $0.00
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: 100.0%
Nov 08, 2022
Sep 30, 2022 (Pre market)
-0.29 Surprise
  • Reported EPS: $-2.49
  • Estimate: $-2.20
  • Whisper: —
  • Surprise %: -13.2%
Jul 01, 2022
Jun 30, 2022 (Pre market)
-0.6 Surprise
  • Reported EPS: $-3.40
  • Estimate: $-2.80
  • Whisper: —
  • Surprise %: -21.4%
Apr 15, 2022
Mar 31, 2022 (Post market)
-0.7 Surprise
  • Reported EPS: $-3.20
  • Estimate: $-2.50
  • Whisper: —
  • Surprise %: -28.0%
Dec 31, 2021
Dec 31, 2021 (Pre market)
-0.04 Surprise
  • Reported EPS: $-0.16
  • Estimate: $-0.12
  • Whisper: —
  • Surprise %: -33.3%
Nov 09, 2021
Sep 30, 2021 (Post market)
-0.6 Surprise
  • Reported EPS: $-2.20
  • Estimate: $-1.60
  • Whisper: —
  • Surprise %: -37.5%
Aug 13, 2021
Jun 30, 2021 (Post market)
0.0 Surprise
  • Reported EPS: $-0.24
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
May 17, 2021
Mar 31, 2021 (Post market)
0.0 Surprise
  • Reported EPS: $0.02
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Mar 11, 2021
Dec 31, 2020 (Post market)
0.0 Surprise
  • Reported EPS: $0.10
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%

Financials